You are here
MDL - 3023 Taxotere (Docetaxel) Eye Injury Products Liability Litigation
- Current Developments
- Pretrial Orders
- Orders/Minute Entries
- Minute Entries
- Case Management Orders
- Calendar
 Order
 Order    
  The Court entered an Order resetting the July 26, 2023 status conference for September 12, 2023, at 9:00 a.m.
 Pretrial Order No. 4
 Pretrial Order No. 4    
  The Court entered Pretrial Order No. 4, setting forth the operable Plaintiff Fact Sheet, authorizations, and Defendant Fact Sheet.
 Order
 Order    
  The Court entered an Order appointing John F. Olinde as Liaison Counsel for the 505(b)(2) Defendants.
 Pretrial Order No. 3
 Pretrial Order No. 3    
  The Court entered Pretrial Order No. 3 requesting applications and nominations for the appointment of liaison counsel for the 505(b)(2) Defendants.
 Order and Reasons
 Order and Reasons    
  The Court ruled on Defendant Sanofi’s Motion to Dismiss for Failure to State a Claim.
 Order and Reasons
 Order and Reasons    
  The Court ruled on the 505(b)(2) Defendants’ Motion to Dismiss for Failure to State a Claim.
 Order
 Order    
  The Court issued an order setting Science Day for December 19, 2022 at 9:00 a.m.
 Minute Entry
 Minute Entry    
  The Court held oral argument on Defendants’ Motions to Dismiss for Failure to State a Claim.
 Order
 Order    
  The Court issued an order denying Defendant McKesson’s Motion to Dismiss as moot.
 Order
 Order    
  The Court issued an order setting oral argument for October 5, 2022 at 10:30 a.m.
 Case Management Order No. 11
 Case Management Order No. 11    
  The Court entered this stipulated order establishing the protocol for streamlined service on Sun Pharmaceuticals, Inc.
 Case Management Order No. 10
 Case Management Order No. 10    
  The Court entered this stipulated order establishing the protocol for streamlined service on Sandoz, Inc.
 Case Management Order No. 9
 Case Management Order No. 9    
  The Court entered this stipulated order establishing the protocol for streamlined service on Hospira Inc., Hospira Worldwide, LLC f/k/a Hospira Worldwide, Inc., and Pfizer Inc.
 Case Management Order No. 8
 Case Management Order No. 8    
  The Court issued this order regarding filing requests for summons and summons returns and waivers.
 Case Management Order No. 7
 Case Management Order No. 7    
  The Court attached the exemplar Short Form Complaint to be used by counsel when filing their complaints as provided by this Order and Case Management Order No. 2.
 Case Management Order No. 6
 Case Management Order No. 6    
  The Court entered this stipulated order establishing the protocol for streamlined service on Sagent Pharmaceuticals, Inc.
 Case Management Order No. 5
 Case Management Order No. 5    
  The Court entered this stipulated order establishing the protocol for streamlined service on Actavis LLC f/k/a Actavis Inc. and Actavis Pharma, Inc.
 Case Management Order No. 4
 Case Management Order No. 4    
  The Court entered this stipulated order establishing the protocol for streamlined service on Accord Healthcare, Inc.
 Case Management Order No. 3
 Case Management Order No. 3    
  The Court entered this stipulated order establishing the protocol for streamlined service on sanofi-aventis U.S. LLC.
 Case Management Order No. 2
 Case Management Order No. 2    
  The Court set certain deadlines for master and short form complaints, motions to dismiss, and master answers.
 Minute Entry,
 Minute Entry,  Joint Report No. 24
 Joint Report No. 24    
  The Court held a general status conference and discussed the items set forth in Joint Report No. 24.
 Minute Entry
 Minute Entry    
  The Court held a conference with lead and liaison counsel and discussed the topics on the attached joint agenda.
 Case Management Order No. 1 ("Direct Filing Order")
 Case Management Order No. 1 ("Direct Filing Order")    
  The Court issued a direct filing order.
 Pretrial Order #2
 Pretrial Order #2    
  The Court appointed liaison counsel and the plaintiffs’ steering committee.
 Minute Entry
 Minute Entry    
  The Court held the initial pretrial conference and discussed the topics on the attached joint agenda.
 Pretrial Order #1
 Pretrial Order #1    
  The Court issued a pretrial order establishing rules and procedures to govern this litigation. The initial pretrial conference will be held on March 31, 2022, at 9:30 a.m. in Judge Jane Triche Milazzo’s courtroom. The Court set the following deadlines:
•    Applications/nominations for the designation of Liaison Counsel must be filed by March 17, 2022. 
•    Position statements are due by March 24, 2022. 
•    Applications/nominations for appointment to the Steering Committee are due by April 7, 2022. 
•    Written objections to applications/nominations for appointment to the Steering Committee are due by April 11, 2022. 
 
 Transfer Order MDL No. 3023
 Transfer Order MDL No. 3023    
  Order received from MDL Panel transferring civil action cases to the Eastern District of Louisiana.
 Pretrial Order No. 4
 Pretrial Order No. 4    
  The Court entered Pretrial Order No. 4, setting forth the operable Plaintiff Fact Sheet, authorizations, and Defendant Fact Sheet.
 Pretrial Order No. 3
 Pretrial Order No. 3    
  The Court entered Pretrial Order No. 3 requesting applications and nominations for the appointment of liaison counsel for the 505(b)(2) Defendants.
 Pretrial Order #2
 Pretrial Order #2    
  The Court appointed liaison counsel and the plaintiffs’ steering committee.
 Pretrial Order #1
 Pretrial Order #1    
  The Court issued a pretrial order establishing rules and procedures to govern this litigation. The initial pretrial conference will be held on March 31, 2022, at 9:30 a.m. in Judge Jane Triche Milazzo’s courtroom. The Court set the following deadlines:
•    Applications/nominations for the designation of Liaison Counsel must be filed by March 17, 2022. 
•    Position statements are due by March 24, 2022. 
•    Applications/nominations for appointment to the Steering Committee are due by April 7, 2022. 
•    Written objections to applications/nominations for appointment to the Steering Committee are due by April 11, 2022. 
 
 Order
 Order    
  The Court entered an Order resetting the July 26, 2023 status conference for September 12, 2023, at 9:00 a.m.
 Order
 Order    
  The Court entered an Order appointing John F. Olinde as Liaison Counsel for the 505(b)(2) Defendants.
 Order and Reasons
 Order and Reasons    
  The Court ruled on Defendant Sanofi’s Motion to Dismiss for Failure to State a Claim.
 Order and Reasons
 Order and Reasons    
  The Court ruled on the 505(b)(2) Defendants’ Motion to Dismiss for Failure to State a Claim.
 Order
 Order    
  The Court issued an order setting Science Day for December 19, 2022 at 9:00 a.m.
 Minute Entry
 Minute Entry    
  The Court held oral argument on Defendants’ Motions to Dismiss for Failure to State a Claim.
 Order
 Order    
  The Court issued an order denying Defendant McKesson’s Motion to Dismiss as moot.
 Order
 Order    
  The Court issued an order setting oral argument for October 5, 2022 at 10:30 a.m.
 Minute Entry,
 Minute Entry,  Joint Report No. 24
 Joint Report No. 24    
  The Court held a general status conference and discussed the items set forth in Joint Report No. 24.
 Minute Entry
 Minute Entry    
  The Court held a conference with lead and liaison counsel and discussed the topics on the attached joint agenda.
 Minute Entry
 Minute Entry    
  The Court held the initial pretrial conference and discussed the topics on the attached joint agenda.
 Case Management Order No. 11
 Case Management Order No. 11    
  The Court entered this stipulated order establishing the protocol for streamlined service on Sun Pharmaceuticals, Inc.
 Case Management Order No. 10
 Case Management Order No. 10    
  The Court entered this stipulated order establishing the protocol for streamlined service on Sandoz, Inc.
 Case Management Order No. 9
 Case Management Order No. 9    
  The Court entered this stipulated order establishing the protocol for streamlined service on Hospira Inc., Hospira Worldwide, LLC f/k/a Hospira Worldwide, Inc., and Pfizer Inc.
 Case Management Order No. 8
 Case Management Order No. 8    
  The Court issued this order regarding filing requests for summons and summons returns and waivers.
 Case Management Order No. 7
 Case Management Order No. 7    
  The Court attached the exemplar Short Form Complaint to be used by counsel when filing their complaints as provided by this Order and Case Management Order No. 2.
 Case Management Order No. 6
 Case Management Order No. 6    
  The Court entered this stipulated order establishing the protocol for streamlined service on Sagent Pharmaceuticals, Inc.
 Case Management Order No. 5
 Case Management Order No. 5    
  The Court entered this stipulated order establishing the protocol for streamlined service on Actavis LLC f/k/a Actavis Inc. and Actavis Pharma, Inc.
 Case Management Order No. 4
 Case Management Order No. 4    
  The Court entered this stipulated order establishing the protocol for streamlined service on Accord Healthcare, Inc.
 Case Management Order No. 3
 Case Management Order No. 3    
  The Court entered this stipulated order establishing the protocol for streamlined service on sanofi-aventis U.S. LLC.
 Case Management Order No. 2
 Case Management Order No. 2    
  The Court set certain deadlines for master and short form complaints, motions to dismiss, and master answers.
 Case Management Order No. 1 ("Direct Filing Order")
 Case Management Order No. 1 ("Direct Filing Order")    
  The Court issued a direct filing order.
Status conference at 9:00 a.m. in Judge Milazzo’s courtroom (C224).
Science Day at 9:00 a.m. in Judge Milazzo’s courtroom (C224).
Oral argument on Defendants’ Motions to Dismiss at 10:30 a.m. in Judge Milazzo’s courtroom (C224).
Lead and Liaison Counsel conference at 1:00 p.m. in Judge Milazzo’s courtroom (C224).
Pretrial conference at 9:30 a.m. in Judge Milazzo’s courtroom (C224).
